The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for cutaneous lymphoma patients.
If you would like to know how to access our trials please click here
Trial Name |
Description |
Click for more information (external page) |
RESMAIN |
Phase 2 study testing resminostat as treatment for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma.
|
|
SOLAR |
Phase 2 study testing a targeted treatment called cobomarsen (also known as MRG-106) in people with a type of T-cell skin lymphoma (cutaneous T-cell lymphoma) called mycosis funcgoides Suitable for patients with lymphoma which has come back after previous treatment
|
|
PORT |
Phase 2 study testing the use of radiotherapy in addition to pembrolizumab for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma
|
*Please note, we update this page fortnightly
With special thanks to the following: